Author, Subjects, Keywords

Cited Author

 

 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

An Open Trial of Risperidone in the Treatment of Schizophrenia In the University of Malaya Medical Centre

Jambunathan, Stephen T., and Aili Hanim Hashim, (2001) An Open Trial of Risperidone in the Treatment of Schizophrenia In the University of Malaya Medical Centre. Malaysian Journal of Psychiatry, 9 (1). pp. 35-42. ISSN 0128-8628

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
369Kb

Affiliations

University of Malaya Medical Centre, Dept. of Psychological Medicine

Abstract

Objective: To apalyze the pattern of use and outcome of patients with Schizophreniatreated with Risperidone over a minimum period of one year In an open labellongitudinal descriptive study.

Item Type:Journal
Additional Information:We thank Seah Li Hwee, Wong Sit Yin, Felicia andfriends for their support and technical help.
Keywords:Treatment of psychotic disorders, risperidone, Asian patients, CGI, GE
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:7493

1.Nair V, Duckworth K Patel J. The NewerAntipsychotic Agents;. Reassessing theTherapeutic Context for Psychosocial Rehabilitation Interventions. Asian Journal of Psychiatry, 1997:5(1): 1-11.

2.Drug Treatment of Schizophrenia in the 1990's.Drugs, 1997: June 53(6): 915.

3.Thomas and Lewis. Which AtypicalAntipsychotic. British Journal of Psychiatry,1998: 172: 106-109.

4.KeksN. Long TermUse ofNovel antipsychotics:Side Effects, Safety and the Risk of NonCompliance. Clinical Courier, 1996: 14(19):4-5.

5.Borison R.L. Assessing the Risks and Benefitsof Antipsychotic Drugs. SchizophreniaReview, March 1996:4(51): 1-2.

6.Kopala L. Objective of Treatment and Experience with Antipsychotics in First Episode Schizophrenia. Schizophrenia Review July,1997 :5(2): 2-3.

7.Borison R.L.The Roleo f Cognition in the Risk-

benefit and Safety Analysis of Antipsychotic Medication. Acta Psychiatrica Scandinavica,1996: 94: 5-11.

8.Green MF, Marshall BD, Wirshing WC et al.Does Risperidone Improve Verbal WorkingMemory in Treatment-resistant Schizophrenia?American Journal of Psychiatry, 1997: 154:799-804.

9.RisperidoneMonograph;Janssen Pharmaceutica.1997.

10.Bondolfi G, Dufour H, Patris M et at.Risperidone Versus Clozapine in Treatment-Resistant Schizophrenia, aRandomized Double-blind Study. American Journal of Psychiatry,1998:155 4):499-504.

11.Abstract. Malt KY, Ng S, Wong MC et al.The Use of Risperidone in the Treatment ofChronic Schizophrenia Patients with Predominating Negative Symptoms, HongKong. University of Hong Kong.

12.Marder SR, Meibach RC. Risperidone inthe Treatment of Schizophrenia. AmericanJournal of Psychiatry, 1994: 151 : 827-835.

13.Littlejohn, Leslie and Cookson. Depot Antipsychotics in Prophylaxis of Bipolar Mood Disorder. Antipsychotics in Bipolar Disorder. British Journal of Psychiatry,1994: 165: 827-829.

14.Conley RR, Buchanan RW. Evaluation of Treatment—Resistant Schizophrenia.Schizophrenia Bulletin, 1997:23(4): 663-674.

15.Bondolfi B, Parris M, Billeter et al. ARandomized Double-blind Trial of Risperidone Versus Clozapine for Treatment-resistant Schizophrenia. Presented at the 8'"congress, Venice, Italy, October 1995.

16. Addington D, Jones B, BloomD etal. Reduction of Hospital Days in Chronic Schizophrenic Patients Treated with Risperidone, a Retrospective Study. Clinical Therapeutics, 1993: 15(5): 917-926

17. Peuskens J. Risperidone in the Treatment of Patients with Chronic Schizophrenia, a Multi-national, Multi-center, Double blind, Parallel-group Study Versus Haloperidol. British Journal of Psychiatry, 1995: 166: 712-726.

18. Schooler N.Maintenance Therapy-Strategiesfor Dose Reduction and Clinical Use. JanssenCilag Medical education service: Risperidone Update: 1-4.

19. Shioritz et al. Cholinergic Rebound and Rapid On set Psychosis Following Abrupt Clozapine Withdrawal. Schizophrenia Bulletin, 199622(4):591-595.

20. Kirov GK, Murray RM, Seth RV et al. Observations on Switching Patients with Schizophrenia to Risperidone Treatment. Acta PsychiatricaScandinavica, 1997: 95:439-443.

21. Jeyarajah S. Open Clinical Risperidone Drug Trial in Malaysia. Presented at the First Asia Pacific Congress on Psychosocial Rehabilitation, Kuala Lumpur Sept 1997.

22. Sharif AZ. An Eight Week Double-blind Comparison of Risperidone and Olanzapine Presented at the Risperidone International Update meeting, Paris, Nov 1, 1998

23. ClausA, Bollen J,De Cuyper Hetal.Risperidone

Versus Haloperidol in Treatment of Chronic Schizophrenic In patients; a Multi-center Double Blind Comparative Study. Acta PsychiatricaScandinavica, 1992:85:295-305.

24. Tran PV, Hamilton SH, Kuntz AJ etal. Double-blind Comparison of Olanzapine Versus Risperidone in the Treatment of Schizophrenia and Other Psychotic Disorders. Journal of Clinical Psychopharmacology, 1997: 17(5) :407-418.

25.Kaplan and Sadock. Synopsis of ClinicalPsychiatry, 7'" edition Chapter 13 : 457-486.

26.Martin SD. Advances in AntipsychoticTreatment-recommended Drugs. Medicine Digest March, 1998: 16(3) : 11-15.

27. Meltzer et al. Recent Advances in thePharmacology of Schizophrenia. ActaPsychiatrica Scandinavica, 1994 (90)(Suppl.384) :95-101.

28. Weiden PJ, Aquila R, DalheimLetal. Switching Antipsychotic Medications. Journal of Clinical Psychiatry, 1997 :58(S10): 63-72

29. JonesBD,Lenunens P .Therapeutic Equivalence of Risperidone Given Once Daily and TwiceDaily in Patients with Schizophrenia Presented at the 8'" ECNP Congress, Venice, Italy, Oct 1995.

30. Luchins DJ, Klass D, Hanrahan P et al. Alteration inthe Recommended Dosing Schedule for Risperidone. American Journal of Psychiatry, 1998 : 155 : 365-366.

Repository Staff Only: item control page